Potential angiotensin I converting enzyme inhibitory peptides from gluten hydrolysate: Biochemical characterization and molecular docking study
暂无分享,去创建一个
A. Asoodeh | M. Lagzian | Zahra Mojallal-Tabatabaei | Leyla Haghighi | Jamashidkhan Chamani | Mohamad Amin Ansari-Ogholbeyk
[1] J. Chamani,et al. Purification and biochemical characterization of angiotensin I-converting enzyme (ACE) from ostrich lung: The effect of 2,2,2-trifluoroethanol on ACE conformation and activity , 2013 .
[2] Joseph Audie,et al. Advances in the Prediction of Protein–Peptide Binding Affinities: Implications for Peptide‐Based Drug Discovery , 2013, Chemical biology & drug design.
[3] A. Camarca,et al. Repertoire of gluten peptides active in celiac disease patients: perspectives for translational therapeutic applications. , 2012, Endocrine, metabolic & immune disorders drug targets.
[4] J. Chamani,et al. Purification and characterisation of angiotensin I converting enzyme inhibitory peptides from lysozyme hydrolysates , 2012 .
[5] Se-kwon Kim,et al. Marine fish-derived bioactive peptides as potential antihypertensive agents. , 2012, Advances in food and nutrition research.
[6] Philippe Vayer,et al. Toward in silico structure-based ADMET prediction in drug discovery. , 2012, Drug discovery today.
[7] W. Burns,et al. Angiotensin-converting enzyme 2 is a key modulator of the renin–angiotensin system in cardiovascular and renal disease , 2011, Current opinion in nephrology and hypertension.
[8] David S. Wishart,et al. DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..
[9] A. Tossi. Design and Engineering Strategies for Synthetic Antimicrobial Peptides , 2011 .
[10] M. Khrestchatisky,et al. Synthetic therapeutic peptides: science and market. , 2010, Drug discovery today.
[11] Suzanne Skolnik,et al. Recent Advances in Physicochemical and ADMET Profiling in Drug Discovery , 2009, Chemistry & biodiversity.
[12] J. Després,et al. Visceral Obesity: The Link Among Inflammation, Hypertension, and Cardiovascular Disease , 2009, Hypertension.
[13] G. Bakris,et al. The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented. , 2009, Kidney international.
[14] Eric A. Decker,et al. Antioxidant Activity of Proteins and Peptides , 2008, Critical reviews in food science and nutrition.
[15] Yong-hui Shi,et al. Novel angiotensin I‐converting enzyme inhibitory peptides isolated from Alcalase hydrolysate of mung bean protein , 2006, Journal of peptide science : an official publication of the European Peptide Society.
[16] O. Kocy,et al. Inhibition of angiotensin-converting enzyme by analogs of peptides fromBothrops jararaca venom , 1973, Experientia.
[17] R. Natesh,et al. Structure of angiotensin I-converting enzyme. , 2004, Cellular and molecular life sciences : CMLS.
[18] P. Shewry,et al. Genetics of wheat gluten proteins. , 2003, Advances in genetics.
[19] A. Fenves,et al. Clinical pharmacology of antihypertensive drugs. , 2002, Cardiology clinics.
[20] R. Fitzgerald,et al. Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme , 2000, British Journal of Nutrition.
[21] R W Piepho,et al. Overview of the angiotensin-converting-enzyme inhibitors. , 2000, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[22] H. Fujita,et al. Classification and Antihypertensive Activity of Angiotensin I-Converting Enzyme Inhibitory Peptides Derived from Food Proteins , 2000 .
[23] G. Mancia,et al. Task force V: White-coat hypertension , 1999 .
[24] G. Mancia,et al. Blood Pressure Monitoring. Task force V: White-coat hypertension. , 1999, Blood pressure monitoring.
[25] G. Pepper. Pharmacology of antihypertensive drugs. , 1999, Journal of obstetric, gynecologic, and neonatal nursing : JOGNN.
[26] N. Yamamoto,et al. Antihypertensive peptides derived from food proteins. , 1997, Biopolymers.
[27] R. Wood. Bronchospasm and cough as adverse reactions to the ACE inhibitors captopril, enalapril and lisinopril. A controlled retrospective cohort study. , 1995, British journal of clinical pharmacology.
[28] M. Yoshikawa,et al. Opioid peptides derived from wheat gluten: Their isolation and characterization , 1992, FEBS letters.
[29] C. Johnston,et al. Characterization of cardiac angiotensin converting enzyme (ACE) and in vivo inhibition following oral quinapril to rats , 1990, British journal of pharmacology.
[30] P. Bünning. The catalytic mechanism of angiotensin converting enzyme. , 1983, Clinical and experimental hypertension. Part A, Theory and practice.
[31] K. Silberbauer,et al. Acute hypotensive effect of captopril in man modified by prostaglandin synthesis inhibition. , 1982, British journal of clinical pharmacology.
[32] J. Riordan,et al. A continuous spectrophotometric assay for angiotensin converting enzyme. , 1979, Analytical biochemistry.